Corporate Governance
Corporate Governance
Alnylam employees, officers, and directors are held to high standards set by
our Board of Directors.
These standards and procedures can be found in the following guidelines.
Governance Guidelines
Charters
| Type | View/Download |
|---|---|
| People, Culture and Compensation Committee | |
| Nominating and Corporate Governance Committee Charter | |
| Audit Committee Charter | |
| Science and Technology Committee Charter |
Executive Leadership Team
We have passionate leaders from the biopharmaceutical industry who bring
together their experiences
of drug discovery, drug development, and commercialization.
Yvonne Greenstreet, MBChB
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Timothy Maines
Chief Technical Operations and Quality Officer
Pushkal Garg, MD
Chief Medical Officer and EVP, Development & Medical Affairs
Tolga Tanguler
Chief Commercial Officer
Indrani Franchini, JD
Chief Legal Officer
Piyush Sharma, JD
Chief Ethics & Compliance Officer
Kelley Boucher
Chief Human Resource Officer
Evan Lippman
Chief Corporate Development & Strategy Officer
Kevin Fitzgerald, PhD
Chief Scientific Officer
Board of Directors
We have a team of accomplished leaders from various backgrounds who elevate our initiatives and strategies.
Chair of the Board: Amy W. Schulman
Audit Committee
Olivier Brandicourt, M.D.
Peter N. Kellogg, Chair
Colleen Reitan
Created to assist the Board of Directors’ oversight of the Company’s accounting and financial reporting processes and the audits of the Company’s financial statements.
People, Culture and Compensation Committee
Colleen Reitan, Chair
Olivier Brandicourt, M.D.
Elliott Sigal,
M.D. Ph.D
Designed to assist the Board of Directors in the discharge of its responsibilities relating to compensation of the Company’s executive officers.
Nominating and Corporate Governance Committee
Dennis A. Ausiello, M.D.
Carolyn Bertozzi, Ph.D
Margaret A. Hamburg, M.D.
David E.I. Pyott,
Chair
Amy W. Schulman
Recommends to the Board the persons to be nominated for election as directors at any meeting of stockholders; develop and recommend to the Board a set of corporate governance principles applicable to the Company; and oversee the evaluation of the Board.
Science and Technology Committee
Dennis A. Ausiello, M.D.
Carolyn Bertozzi,
Ph.D
Phillip A.
Sharp, Ph.D, Chair
Elliott Sigal, M.D. Ph.D
Assists the Board’s oversight of the Company’s research and development activities and to advise the Board with respect to strategic and tactical scientific issues.
Looking for specific information that isn't listed above?
Contact: investors@alnylam.com